PEAK BIO, INC.
None
None, None [HQ]
Ratios
5 Records · Starting from 2019Margins, Growth Rates In %
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross Margin | - - | - - | 100.00 | 99.98 | 99.97 | |
| Profit Margin | - - | - - | -1,569.65 | -2,153.88 | -0.34 | |
| Operating Margin | - - | - - | -1,715.95 | -1,949.68 | -0.38 | |
|
EPS Growth
|
- - | -33.33 | -119,900.00 | -54.17 | 100.00 | |
| EPS USD | -0.03 | -0.04 | -48.00 | -74.00 | - - | |
| Return on Assets (ROA) | -10.69 | -23.85 | -769.07 | -173.83 | -0.05 | |
| Return on Equity (ROE) | -11.22 | -24.24 | 428.50 | 161.70 | 0.01 | |
| Return on Invested Capital (ROIC) | -10.96 | -23.56 | 2,103.56 | 472.77 | 0.02 | |
| Solvency | ||||||
| Equity Ratio | - - | - - | -100 | -100 | -600 | |
| Debt/Assets | - - | - - | 139.11 | 74.41 | 412.95 | |
| Debt/Equity | - - | - - | -77.51 | -69.21 | -59.05 | |
| Debt/EBITDA | 897.46 | 326.37 | -14.56 | -41.65 | -762,420.08 | |
|
Debt/Capitalization
|
- - | - - | -344.62 | -224.83 | -144.20 | |
| Long-Term Debt/Capitalization | - - | - - | - - | -76.46 | - - | |
| Interest Debt per Share USD | - - | - - | 0.09 | 0.32 | 0.27 | |
| Debt Growth | - - | - - | - - | 273.50 | 91.37 | |
| Liquidity | ||||||
| Current Ratio | 1,993.17 | 4,700.59 | 16.45 | 29.91 | 11.57 | |
| Quick Ratio | 1,993.17 | 4,700.59 | 16.45 | 23,848,468.13 | 2.23 | |
| Cash Ratio | 1,988.13 | 4,593.84 | 7.36 | 6.06 | 1.86 | |
| Operating Cash Flow Ratio | -100 | -1,200 | -300 | - - | - - | |
| Turnover | ||||||
| Inventory Turnover | - - | - - | - - | - - | 0.01 | |
| Receivables Turnover | - - | - - | - - | 248.06 | 489.25 | |
| Payables Turnover | - - | - - | - - | - - | - - | |
|
Asset Turnover
|
- - | - - | 49.00 | 8.07 | 14.17 | |
| Fixed Turnover | - - | - - | 138.81 | 14.98 | 240.27 | |
| Coverage | ||||||
| Interest Coverage | - - | - - | -79,029.99 | -24,704.63 | 0.05 | |
| Asset Coverage | - - | - - | - - | - - | - - | |
| Cash Flow Coverage (CFGR) | - - | - - | -590.95 | -133.61 | -44.38 | |
| EBITDA Coverage | - - | - - | -77,400 | -24,700 | - - | |
| Dividend Coverage | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | 27,100 | |
| Market Prospects | ||||||
| Dividend Yield | - - | - - | - - | - - | - - | |
| Earnings Yield | - - | - - | -4.96 | -17.64 | -0.02 | |
|
Price/Earnings (P/E)
|
-27,793.6037 | -26,457.4030 | -20.1584 | -5.6700 | -4,398.9235 | |
| Price/Earnings Growth (PEG) | - - | -79,372.21 | -0.02 | -10.47 | 4,398.92 | |
|
Price/Book (P/B)
|
311,795.01 | 641,292.84 | -8,637.83 | -916.83 | -30.51 | |
| Price/Tangible Book (P/TB) | 311,795.01 | 641,292.84 | -8,637.83 | -916.83 | -30.51 | |
| Price/Sales (P/S) | - - | - - | 31,641.54 | 12,212.43 | 1,505.77 | |
|
Price/Cash Flow (P/CF)
|
-3,373,477.77 | -3,190,500.10 | -1,885.84 | -991.40 | -116.42 | |
| Price/Free CF (P/FCF) | -3,033,964.33 | -3,041,954.09 | -1,883.74 | -972.91 | -116.42 | |
| Price/Operating CF (P/OCF) | -3,373,477.77 | -3,190,500.10 | -1,885.84 | -991.40 | -116.42 |